Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Volitionrx Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −7 vs. Q1 2026
- Shares held
- 1.93M
- +811.3K (+72.5%) vs. Q1 2026Converted for a 1-for-20 split
- Total value
- $2.61M
- −$1.91M (−42.3%) vs. Q1 2026
- New holders
- 5
- 7 more added
- Sold out
- 12
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 1,455,950 | $1.97M | 1.08% | +648,500+80.3% | AddedConverted for a 1-for-20 split |
| Luminus Management LLC | 156,897 | $211.8K | 0.14% | +107,147+215.4% | AddedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 55,537 | $75.0K | 0.00% | −5,967−9.7% | ReducedConverted for a 1-for-20 split |
| Vanguard Capital Management LLC | 50,684 | $68.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Wealthspire Advisors, LLC | 45,000 | $60.8K | 0.00% | +34,000+309.1% | AddedConverted for a 1-for-20 split |
| State Street Corp | 33,995 | $45.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| XTX Topco Ltd | 25,381 | $34.3K | 0.00% | +23,078+1,002.1% | AddedConverted for a 1-for-20 split |
| Vanguard Fiduciary Trust Co | 25,133 | $33.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BlackRock, Inc. | 22,308 | $30.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Northern Trust Corp | 12,978 | $17.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Silverberg Bernstein Capital Management LLC | 12,520 | $16.9K | 0.01% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Squarepoint Ops LLC | 10,685 | $14.4K | 0.00% | +10,685 | New |
| Tower Research Capital LLC (TRC) | 5,768 | $7.79K | 0.00% | +3,952+217.6% | AddedConverted for a 1-for-20 split |
| SRS Capital Advisors, Inc. | 5,552 | $7.50K | 0.00% | +5,552 | New |
| UBS Group AG | 4,419 | $5.97K | 0.00% | −5,953−57.4% | ReducedConverted for a 1-for-20 split |
| Group One Trading, L.P. | 2,500 | $3.38K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Simplex Trading, LLC | 2,174 | $2.93K | 0.00% | +2,174 | New |
| Northwestern Mutual Wealth Management Co | 1,999 | $2.70K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Barclays PLC | 357 | $482 | 0.00% | +357 | New |
| SBI Securities Co., Ltd. | 188 | $254 | 0.00% | +108+135.0% | AddedConverted for a 1-for-20 split |
| Morgan Stanley | 31 | $42 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Advisor Group Holdings, Inc. | 21 | $28 | 0.00% | −1−2.3% | ReducedConverted for a 1-for-20 split |
| BNP Paribas Arbitrage, SA | 14 | $19 | 0.00% | +1+5.7% | AddedConverted for a 1-for-20 split |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −2,780−100.0% | Sold outConverted for a 1-for-20 split |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −2,028−100.0% | Sold outConverted for a 1-for-20 split |
| Miller Financial Services LLC | 0 | $0 | 0.00% | −1,550−100.0% | Sold outConverted for a 1-for-20 split |
| PFG Investments, LLC | 0 | $0 | 0.00% | −1,250−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −789−100.0% | Sold outConverted for a 1-for-20 split |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −750−100.0% | Sold outConverted for a 1-for-20 split |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −686−100.0% | Sold outConverted for a 1-for-20 split |
| Creative Planning | 0 | $0 | 0.00% | −642−100.0% | Sold outConverted for a 1-for-20 split |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-20 split |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −600−100.0% | Sold outConverted for a 1-for-20 split |
| Citigroup Inc | 0 | $0 | 0.00% | −436−100.0% | Sold outConverted for a 1-for-20 split |
| Hickory Point Bank & Trust | 0 | $0 | 0.00% | −250−100.0% | Sold outConverted for a 1-for-20 split |